<DOC>
	<DOCNO>NCT01263704</DOCNO>
	<brief_summary>This single arm , open-label study ass safety efficacy low dose fludarabine cyclophosphamide combination standard dose MabThera/Rituxan ( rituximab ) primary therapy elderly patient ( &gt; /= 65 year ) chronic lymphocytic leukemia . Patients receive six 28-day cycle treatment Mabthera/Rituxan ( 375 mg/m2 intravenously [ iv ] Day 0 cycle 1 , 500 mg/m2 iv Day 1 cycle 2-6 ) , fludarabine ( 12.5 mg/m2/d iv Days 1-3 , cycle 1-6 ) cyclophosphamide ( 150 mg/m2/d iv Days 1-3 , cycle 1-6 ) . Anticipated time study treatment 6 month , 30-month follow-up period .</brief_summary>
	<brief_title>A Study MabThera/Rituxan ( Rituximab ) Combination With Fludarabine And Cyclophosphamide Primary Therapy Elderly Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Adult patient , &gt; /= 65 year age Previously untreated Bcell chronic lymphocytic leukemia ( CLL ) Binet stage C active Binet stage A B disease Prior treatment CLL CLL transformation ( Richter 's syndrome ) Suspected know CNS involvement CLL Impaired renal hepatic function HIV positivity , active hepatitis B/C HBV surface antigen positive , active uncontrolled infection Patients antiHBV core antibody ( past infection HBV ) negative HBVsAg ( either antiHBS Ab positive negative ) positive HBVDNA PCR analysis Concomitant diseases require chronic steroid administration Active second malignancy within 2 year prior study ( except nonmelanoma skin cancer situ cervix breast prostate carcinoma ) ECOG performance status &gt; /= 3</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>